Our Pricing

Mounjaro New UK Prices - All Doses Available Now

Published on: June 03, 2026

Searching for Mounjaro new UK prices all doses with immediate availability? At Cured Pharmacy, all Mounjaro (tirzepatide) doses from 2.5mg to 15mg are in stock now, starting from £124.99, with transparent upfront pricing and free clinical consultation by UK-registered prescribers. Every prescription requires a clinical assessment to ensure Mounjaro is safe and appropriate for your weight management goals.

Mounjaro New UK Prices: All Doses Explained

Mounjaro (tirzepatide) is available in six doses across the UK: 2.5mg, 5mg, 7.5mg, 10mg, 12.5mg, and 15mg KwikPen injections. At Cured Pharmacy, pricing starts from £124.99, with the final cost determined by your prescribed dose following clinical assessment by a UK prescriber registered with the General Pharmaceutical Council.

Unlike many online pharmacies that advertise low entry prices but lack stock across higher doses, we maintain full availability of all Mounjaro doses. This ensures continuity of care as you progress through the recommended dose escalation schedule, which typically begins at 2.5mg and increases every four weeks to minimise gastrointestinal side effects [1].

All prices are displayed upfront before your consultation begins—no hidden fees, no surprise charges at checkout. Our superintendent pharmacist, Tarun Kumar (GPhC 2233073), oversees every prescription to ensure clinical safety and regulatory compliance with MHRA guidelines.

How Mounjaro (Tirzepatide) Works for Weight Loss

Mounjaro contains tirzepatide, the first dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist licensed by the MHRA for chronic weight management in the UK [1]. This dual mechanism distinguishes it from single-pathway GLP-1 treatments, activating two complementary hormonal pathways that regulate appetite, slow gastric emptying, and improve insulin sensitivity.

In the landmark SURMOUNT-1 trial, participants receiving the 15mg maintenance dose achieved an average body weight reduction of 22.5% over 72 weeks—significantly greater than placebo and exceeding results seen with semaglutide-based treatments in head-to-head comparisons [1][2]. The dual agonist action appears to produce more pronounced satiety signals and metabolic improvements than GLP-1 activation alone.

Clinical trials demonstrated that tirzepatide not only supports weight reduction but also improves cardiovascular risk markers including blood pressure, lipid profiles, and glycaemic control in patients with type 2 diabetes [3]. However, Mounjaro is prescribed for weight management in adults with a BMI of 30 kg/m² or greater, or 27 kg/m² with at least one weight-related comorbidity, subject to prescriber assessment.

Expected Timeline and Results

Most patients begin noticing appetite reduction within the first two weeks of starting Mounjaro, though measurable weight loss typically becomes evident after four to eight weeks [1]. The dose escalation protocol—starting at 2.5mg and increasing every four weeks—allows your body to adjust gradually, reducing the likelihood of nausea and other gastrointestinal effects that can occur with GLP-1 receptor agonists.

Peak efficacy is generally observed at the 10mg, 12.5mg, or 15mg maintenance doses, which are reached after approximately 16 to 20 weeks of treatment. Your UK prescriber will determine the optimal maintenance dose based on your individual response, tolerability, and weight management goals during ongoing clinical reviews.

Mounjaro vs Wegovy: Comparing UK Weight Loss Injections

Both Mounjaro (tirzepatide) and Wegovy (semaglutide) are once-weekly injectable treatments licensed by the MHRA for chronic weight management, but they differ in their mechanisms of action and clinical outcomes. Wegovy activates only GLP-1 receptors, while Mounjaro activates both GLP-1 and GIP receptors, producing dual hormonal effects on appetite regulation and metabolism [1][2].

In direct comparative analysis of clinical trial data, tirzepatide demonstrated superior average weight reduction compared to semaglutide. The SURMOUNT-1 trial reported up to 22.5% body weight reduction with tirzepatide 15mg, whereas the STEP 1 trial showed up to 14.9% reduction with semaglutide 2.4mg over similar timeframes [1][2]. Individual responses vary, and some patients may achieve better results or tolerability with one medication over the other.

At Cured Pharmacy, Wegovy is available from £135.00 offering a lower entry price point than Mounjaro. Your UK prescriber will assess your medical history, previous weight loss attempts, contraindications, and budget considerations to recommend the most appropriate treatment. Both medications require ongoing clinical monitoring and are most effective when combined with dietary modifications and increased physical activity.

Which Treatment Is Right for You?

Choosing between Mounjaro and Wegovy depends on multiple clinical factors including your BMI, weight-related comorbidities, previous treatment responses, and any contraindications. Patients with type 2 diabetes may benefit from tirzepatide's superior glycaemic control effects, while those seeking the most cost-effective option may prefer Wegovy's lower starting price.

Your free online consultation with a UK prescriber at Cured Pharmacy takes under three minutes and includes a comprehensive assessment of your suitability for either treatment. Our clinical team will discuss expected outcomes, potential side effects, and the dose escalation schedule before issuing any prescription, ensuring you make an informed decision about your weight management journey.

Mounjaro Dosing Schedule and All Available Doses

The recommended Mounjaro dosing protocol begins with 2.5mg once weekly for the first four weeks, serving as an initial dose to assess tolerability and allow your body to adapt to GLP-1/GIP receptor activation. After four weeks, the dose is typically increased to 5mg weekly, then escalated by 2.5mg increments every four weeks until reaching an effective maintenance dose [4].

All six Mounjaro doses are currently available at Cured Pharmacy: 2.5mg, 5mg, 7.5mg, 10mg, 12.5mg, and 15mg KwikPen injections. This complete dose range ensures uninterrupted treatment progression as you titrate upward, avoiding the supply disruptions that have affected some UK pharmacies in recent months. Each KwikPen contains four weekly doses, delivered subcutaneously into the abdomen, thigh, or upper arm.

Your prescriber will determine the optimal maintenance dose based on your weight loss response and tolerability. Clinical trials showed that higher doses generally produced greater weight reduction, but some patients achieve their goals at lower doses with fewer side effects [1]. Dose adjustments are made during regular clinical reviews, which can be completed online through your Cured Pharmacy account.

Common Side Effects and How to Manage Them

The most frequently reported side effects of Mounjaro are gastrointestinal in nature, including nausea, diarrhoea, vomiting, constipation, and abdominal discomfort. In clinical trials, these effects were generally mild to moderate in severity and diminished over time as patients continued treatment [1]. The gradual dose escalation protocol is specifically designed to minimise these gastrointestinal symptoms.

Nausea typically peaks during the first few weeks after each dose increase and often resolves within days as your body adjusts. Eating smaller, more frequent meals, avoiding high-fat foods, and staying well-hydrated can help manage these symptoms. If nausea persists or becomes severe, contact your prescriber—they may recommend maintaining your current dose for an additional four weeks before escalating further.

Rare but serious side effects include pancreatitis, gallbladder disease, and thyroid C-cell tumours (observed in animal studies but not conclusively demonstrated in humans) [4]. Mounjaro is contraindicated in patients with a personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2. Your UK prescriber will review your complete medical history during consultation to identify any contraindications before prescribing.

When to Contact Your Prescriber

Seek immediate medical attention if you experience severe abdominal pain that does not resolve, persistent vomiting preventing fluid intake, signs of pancreatitis (upper abdominal pain radiating to the back), or symptoms of gallbladder disease (yellowing of skin or eyes, dark urine, pale stools). These symptoms, while uncommon, require urgent clinical assessment.

Contact your Cured Pharmacy prescriber if you experience hypoglycaemia symptoms (dizziness, sweating, confusion) particularly if you are taking Mounjaro alongside other diabetes medications, or if gastrointestinal side effects persist beyond two weeks and significantly impact your quality of life. Our clinical team is available via phone on (+44) 116 4646009 during business hours for any treatment concerns.

How to Order Mounjaro from Cured Pharmacy

Ordering Mounjaro from Cured Pharmacy begins with a free online consultation that takes under three minutes to complete. You'll answer questions about your medical history, current medications, weight management goals, and any contraindications. This assessment is reviewed by a UK-registered prescriber who will determine whether Mounjaro is clinically appropriate and safe for you.

If approved, your prescription is issued electronically and sent directly to our GPhC-registered pharmacy (registration number 9012511) for dispensing. All Mounjaro pens are genuine UK-licensed medicines sourced through regulated supply chains and stored in accordance with MHRA cold chain requirements. We dispatch orders in 100% discreet packaging via tracked courier, with most deliveries arriving within 2-3 working days across the UK.

Pricing is transparent and displayed before you begin your consultation—no hidden fees or surprise charges. The assessment is completely free, and you only pay if your prescription is approved and you choose to proceed with the order. Ongoing prescriptions can be managed through your online account, with regular clinical reviews ensuring continued safety and efficacy throughout your weight management journey.

Lowest Price Guarantee

At Cured Pharmacy, we guarantee the lowest Mounjaro prices in the UK. If you find a lower price from another UK-registered pharmacy for the same dose and quantity, we will match it. Our commitment to competitive pricing ensures you receive genuine, licensed medication without paying premium rates charged by some online providers.

All patients ordering weight loss treatments receive £135.00 off their first order, making Mounjaro even more accessible for those beginning their weight management journey. Simply complete your free consultation to see your personalised pricing and available discounts before committing to purchase.

Scientific References

1. Jastreboff, A. M., Aronne, L. J., Ahmad, N. N., Wharton, S., Connery, L., Alves, B., Kiyosue, A., Zhang, S., Liu, B., Bunck, M. C., & Stefanski, A. (2022). Tirzepatide Once Weekly for the Treatment of Obesity. New England Journal of Medicine, 387(3), 205–216. https://doi.org/10.1056/NEJMoa2206038 [accessed 13 August 2026]
2. Wilding, J. P. H., Batterham, R. L., Calanna, S., Davies, M., Van Gaal, L. F., Lingvay, I., McGowan, B. M., Rosenstock, J., Tran, M. T. D., Wadden, T. A., Wharton, S., Yokote, K., Zeuthen, N., & Kushner, R. F. (2021). Once-Weekly Semaglutide in Adults with Overweight or Obesity. New England Journal of Medicine, 384(11), 989–1002. https://doi.org/10.1056/NEJMoa2032183 [accessed 13 August 2026]
3. Rosenstock, J., Wysham, C., Frías, J. P., Kaneko, S., Lee, C. J., Fernández Landó, L., Mao, H., Cui, X., Karanikas, C. A., & Thieu, V. T. (2021). Efficacy and safety of a novel dual GIP and GLP-1 receptor agonist tirzepatide in patients with type 2 diabetes (SURPASS-1): a double-blind, randomised, phase 3 trial. The Lancet, 398(10295), 143–155. https://doi.org/10.1016/S0140-6736(21)01324-6 [accessed 13 August 2026]
4. Electronic Medicines Compendium (eMC). (2023). Mounjaro 2.5 mg solution for injection in pre-filled pen - Summary of Product Characteristics (SmPC). Retrieved from https://www.medicines.org.uk/emc/product/14298/smpc [accessed 13 August 2026]
5. NHS. (2026). Tirzepatide: a medicine to manage type 2 diabetes and treat obesity. https://www.nhs.uk/medicines/tirzepatide/ Accessed 13 August 2026.
6. NHS. (2026). Overweight and obesity in adults. https://www.nhs.uk/conditions/overweight-and-obesity/ Accessed 13 August 2026.
7. NHS England. (2026). Weight management injections. https://www.england.nhs.uk/ourwork/prevention/obesity/medicines-for-obesity/weight-management-injections/ Accessed 13 August 2026.

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Mounjaro (tirzepatide) is indicated for chronic weight management in adults with a BMI ≥30 kg/m² or ≥27 kg/m² with weight-related comorbidities, as an adjunct to a reduced-calorie diet and increased physical activity. Always consult a qualified healthcare professional before starting any new medication. Individual results may vary.